Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy

Bibliographic Details
Main Authors: Kelsey Hirotsu, MD, Albert S. Chiou, MD, Audris Chiang, BA, Jinah Kim, MD, PhD, Bernice Y. Kwong, MD, Silvina Pugliese, MD
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512617301169
_version_ 1819041837141196800
author Kelsey Hirotsu, MD
Albert S. Chiou, MD
Audris Chiang, BA
Jinah Kim, MD, PhD
Bernice Y. Kwong, MD
Silvina Pugliese, MD
author_facet Kelsey Hirotsu, MD
Albert S. Chiou, MD
Audris Chiang, BA
Jinah Kim, MD, PhD
Bernice Y. Kwong, MD
Silvina Pugliese, MD
author_sort Kelsey Hirotsu, MD
collection DOAJ
first_indexed 2024-12-21T09:31:20Z
format Article
id doaj.art-2c3ca85ff558418597b68667aaf3ef49
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-12-21T09:31:20Z
publishDate 2017-09-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-2c3ca85ff558418597b68667aaf3ef492022-12-21T19:08:44ZengElsevierJAAD Case Reports2352-51262017-09-013540440610.1016/j.jdcr.2017.06.004Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapyKelsey Hirotsu, MD0Albert S. Chiou, MD1Audris Chiang, BA2Jinah Kim, MD, PhD3Bernice Y. Kwong, MD4Silvina Pugliese, MD5Department of Dermatology, Stanford University School of Medicine, Stanford, CaliforniaDepartment of Dermatology, Stanford University School of Medicine, Stanford, CaliforniaUniversity of California, Irvine School of Medicine, Irvine, CaliforniaDepartment of Dermatology, Stanford University School of Medicine, Stanford, CaliforniaDepartment of Dermatology, Stanford University School of Medicine, Stanford, CaliforniaDepartment of Dermatology, Stanford University School of Medicine, Stanford, Californiahttp://www.sciencedirect.com/science/article/pii/S2352512617301169bullous pemphigoidprogrammed cell death receptor 1 inhibitionradiation
spellingShingle Kelsey Hirotsu, MD
Albert S. Chiou, MD
Audris Chiang, BA
Jinah Kim, MD, PhD
Bernice Y. Kwong, MD
Silvina Pugliese, MD
Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
JAAD Case Reports
bullous pemphigoid
programmed cell death receptor 1 inhibition
radiation
title Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
title_full Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
title_fullStr Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
title_full_unstemmed Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
title_short Localized bullous pemphigoid in a melanoma patient with dual exposure to PD-1 checkpoint inhibition and radiation therapy
title_sort localized bullous pemphigoid in a melanoma patient with dual exposure to pd 1 checkpoint inhibition and radiation therapy
topic bullous pemphigoid
programmed cell death receptor 1 inhibition
radiation
url http://www.sciencedirect.com/science/article/pii/S2352512617301169
work_keys_str_mv AT kelseyhirotsumd localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy
AT albertschioumd localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy
AT audrischiangba localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy
AT jinahkimmdphd localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy
AT berniceykwongmd localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy
AT silvinapugliesemd localizedbullouspemphigoidinamelanomapatientwithdualexposuretopd1checkpointinhibitionandradiationtherapy